Differential (Click to cross reference) advances in neurology adverse drug reaction aggrenox algorithm anticoagulant, complications of anticoagulant, contraindications anticoagulant, discontinuation anticoagulant, treatment anticoagulant, treatment in CVD anticoagulant, treatment, combined antihypertensive aorta, atherosclerosis aortic arch ulcerated plaques aphasia apixaban aspirin aspirin, dose of aspirin, failure of aspirin, rectal atrial fibrillation atrial fibrillation, risk stratification blacks bleeding disorder blood pressure, control bruising carotid artery atherosclerosis carotid artery disease carotid artery disease, medical management carotid artery stenosis carotid artery stenosis, intracranial carotid artery stenosis, risk of stroke with carotid artery stenosis, surgical treatment carotid artery stenosis, symptomatic cerebral atherosclerosis cerebral atherosclerosis, medical management cerebral infarction cerebral infarction, small, deep cerebral ischemia cerebrovascular accident cerebrovascular accident, acute management of cerebrovascular accident, infancy and childhood cerebrovascular accident, model for predicting risk of cerebrovascular accident, platelet inhibiting drugs in treatment cerebrovascular accident, prevention of cerebrovascular accident, primary prevention cerebrovascular accident, recurrent cerebrovascular accident, secondary prevention cerebrovascular accident, thrombolytic agents in treatment cerebrovascular accident, time to treatment cerebrovascular accident, women CHADS-VaSC score CHANCE Trial CHARISMA children cilostazol clopidogrel coma complications confusion contraindications controversies in neurology coronary artery disease cost effectiveness coumadin, eligibility for coumarin craniectomy, decompressive dabigatran decision analysis dementia diabetes mellitus dipyridamole disorientation drug interactions efficacy embolism, silent emergencies, medical emergencies, neurologic endarterectomy, carotid endarterectomy, carotid-complications of endarterectomy, carotid-indications for endovascular therapy evidence-based research factor Xa inhibitor fever fibrinolytic agents fibrinolytic agents, complications gastrointestinal bleeding gender genetic testing headache headache, drug induced hematoma, epidural-spinal hemophilia hemorrhagic diathesis hemorrhoidectomy hemorrhoids hypertension iatrogenic neurologic disorders INR values intellectual deterioration intracerebral hemorrhage intracerebral hemorrhage, treatment of intracranial hemorrhage Irbesartan lacunar infarction lumbar puncture lumbar puncture, complications of MATCH trial microangiopathic hemolytic anemia middle cerebral artery atherosclerosis migraine mortality MRI, abnormal MRI, angiography MRI, diffusion weighted MRI, timing after stroke multimodal neuroimaging myocardial infarction myocardial infarction, acute neurologic disease, diagnoses of old age, neurology of omeprazole PFA-100 plasmapheresis platelet function test platelet inhibiting drugs platelet inhibiting drugs, combined platelet inhibiting drugs, discontinuation platelet transfusion POINT trial practice guidelines prevention of neurologic disorders PROFESS trial proton pump inhibitors race renal failure review article risk factors risk factors, modification risk-benefit assessment rivaroxaban safety screening slurred speech statin therapy symptomatic thrombin inhibitor thrombocytopenia thrombotic thrombocytopenia purpura ticagrelor ticlopidine tissue plasminogen activator, intravenous transient ischemic attack transient ischemic attack, evaluation transient ischemic attack, treatment of transluminal angioplasty, intracranial treatment of neurologic disorder vertebral-basilar artery, atherosclerosis vitamin K antagonist workup

Showing articles 50 to 57 of 57 << Previous Cost-Effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack Arch Int Med 160:2773-2778, Sarasin,F.P.,et al, 2000 Secondary Prevention after Cerebral Ischaemia of Presumed Arterial Origin:Is Aspirin Still the Touchstone? JNNP 66:557-559, Algra,A.,et al, 1999 Antiplatelet Therapy in Acute Cerebral Ischemia Stroke 30:887-893, Bednar,M.M.&Gross,C.E., 1999 Therapeutic Benefit, Aspirin Revisited in Light of the Introduction of Clopidogrel Stroke 30:1716-1721, Gorelick,P.B.,et al, 1999 Antiplatelet Therapy:Views from the Experts Neurol 53:S32-S37, Easton,J.D.,et al, 1999 Clopidogrel for Reduction of Atherosclerotic Events The Medical Letter 40:59-60, , 1998 The Antiplatelet Effects of Ticlopidine and Clopidogrel Ann Int Med 129:394-405, Sharis,P.J.,et al, 1998 A Randomised Blinded Trial of Clopidogrel vs. Aspirin in Patients at Risk of Ischaemic Events (CAPRIE) , CAPRIE S, eerimte,Lancet 348:1329-1339,1996., 1996 Showing articles 50 to 57 of 57 << Previous